-
Cohen Veterans Bioscience and Parexel Biotech Collaborate on Landmark Adaptive Platform Trial Studying Posttraumatic Stress Disorder (PTSD) Pharmacotherapeutics
November 11, 2019Cohen Veterans Bioscience announced its strategic collaboration with Parexel Biotech, a new division of Parexel, for CVB’s adaptive platform…
-
Landmark Study Identifies Six Genetic Markers of Post-Traumatic Stress Disorder (PTSD) Risk
October 8, 2019Cohen Veterans Bioscience and the Stanley Center for Psychiatric Research at the Broad Institute at MIT and Harvard, announce…
-
Cohen Veterans Bioscience Issues National PTSD Awareness Day Progress Report
June 27, 2019Read our progress update on critical post-traumatic stress disorder (PTSD) programs, and proceedings from the first State of the…
-
Study Identifies Post-Traumatic Stress Disorder (PTSD) Brain Imaging Biomarker
April 8, 2019Cohen Veterans Bioscience announces findings from a study which identifies a critical brain imaging biomarker that may help guide…
-
CDISC and Cohen Veterans Bioscience Announce Release of First Data Standard to Improve Research for Post Traumatic Stress Disorder
December 12, 2018CDISC and Cohen Veterans Bioscience are pleased to announce the publication of a new Therapeutic Area (TA) Standard for Post Traumatic…
-
The Michael J. Fox Foundation Partners with Cohen Veterans Bioscience on BRAIN Commons, Harnessing the Power of Big Data for Brain Diseases
October 11, 2018The Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Cohen Veterans Bioscience announce their partnership on BRAIN Commons, a…
-
Cohen Veterans Bioscience Receives Research Award from Department of Defense’s Medical Research and Materiel Command to Establish A Clinical Trial Infrastructure and Conduct an Adaptive Platform Trial Testing Post-Traumatic Stress Disorder (PTSD) Pharmacotherapeutics
October 4, 2018Cohen Veterans Bioscience will establish a clinical trial infrastructure and serve as the Clinical Coordinating Center for a 3.5-year...
-
Cohen Veterans Bioscience Expands Digital Health Platform with Early Signal Expertise
September 6, 2018Early Signal subsidiary will expand CVB’s role as a hub for translational research and data analytics to fast-track solutions...
-
Brainsway and Cohen Veterans Bioscience Announce Biomarker Research Collaboration in Post Traumatic Stress Disorder
June 7, 2018Brainsway, a leader in the advanced non-invasive treatment of brain disorders, and Cohen Veterans Bioscience today announced the launch of…
-
Cohen Veterans Bioscience Releases Harris Poll Assessing Awareness of PTSD in U.S. Military Veterans
April 19, 2018Cohen Veterans Bioscience today announced results of a Harris Poll survey of over 2000 respondents revealing that nearly 9…
Press Releases
